Skip to main content
Erschienen in: PharmacoEconomics 15/2003

01.10.2003 | Original Research Article

Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden

A study on patients’ burden of disease

verfasst von: Roger Jones, Silke Horbach, Dr Peter Sander, Tina Rydén-Bergsten

Erschienen in: PharmacoEconomics | Ausgabe 15/2003

Einloggen, um Zugang zu erhalten

Abstract

Background: Gastro-oesophageal reflux disease (GORD) is widespread in the general population and presents in most cases with heartburn as the main symptom. The severity of symptoms is not necessarily related to erosive damage to the oesophagus due to acid reflux, but the frequency and severity of symptoms have an impact on the health-related QOL (HR-QOL) of the patient.
Objective: To characterise patients with GORD who consult a physician because of heartburn with respect to medical background and burden of disease in Germany and Sweden.
Methods: A total of 1011 patients who had been experiencing symptoms of GORD, including heartburn, for at least 1 year were recruited by physicians, who collected data on the patients’ previous diagnosis and treatment. The patients themselves were interviewed by telephone about their heartburn. The EuroQOL 5-dimensional HR-QOL questionnaire (EQ-5D) and the Gastrointestinal Symptom Rating Scale (GSRS) were used to measure patient-reported outcomes.
Results: About half of the patients had been experiencing symptoms of GORD for >5 years. The majority (54%) perceived the severity of their heartburn as moderate. Thirty-eight percent of the patients had been examined by endoscopy during the last 12 months and 79% of these had macroscopic oesophagitis. Medical treatment for heartburn had been prescribed to 88% of the patients. The mean annual number of days with heartburn was assessed as 170 days per patient, with the majority of patients (64%) experiencing heartburn every week. HR-QOL was reduced in these patients as expressed by EQ-5D scores compared to scores for a general population. Patients with GORD had problems related to gastrointestinal symptoms as rated by GSRS scores. More severe heartburn was associated with a greater number of symptom days and reduced HR-QOL scores, whereas a relationship between the findings at endoscopy and the severity of symptoms or HR-QOL could not be found.
Conclusion: This study demonstrates that heartburn confers a significant burden on patients with GORD, related to the frequency and severity of symptoms and reflected in the reduction in HR-QOL as perceived by the patients.
Literatur
1.
2.
Zurück zum Zitat Katz PO. Gastroesophageal reflux disease. J Am Geriatr Soc 1998; 46: 1558–65PubMed Katz PO. Gastroesophageal reflux disease. J Am Geriatr Soc 1998; 46: 1558–65PubMed
3.
Zurück zum Zitat Green JA, Amaro R, Barkin JS. Just a little heartburn? Am J Gastroenterol 2000; 95: 813–4PubMed Green JA, Amaro R, Barkin JS. Just a little heartburn? Am J Gastroenterol 2000; 95: 813–4PubMed
4.
Zurück zum Zitat Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825–31PubMedCrossRef Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825–31PubMedCrossRef
5.
Zurück zum Zitat Valle C, Broglia F, Pistorio A, et al. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci 1999; 44: 1848–52PubMedCrossRef Valle C, Broglia F, Pistorio A, et al. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci 1999; 44: 1848–52PubMedCrossRef
6.
Zurück zum Zitat Ruth J, Mansson J, Sandberg N. The prevalence of symptoms of esophageal disorders. Scand J Gastroenterol 1991; 26: 73–81PubMedCrossRef Ruth J, Mansson J, Sandberg N. The prevalence of symptoms of esophageal disorders. Scand J Gastroenterol 1991; 26: 73–81PubMedCrossRef
7.
Zurück zum Zitat Nebel OT, Forties MF, Castell DO. Symptomatic gastroesophageal reflux incidence and precipitating factors. Am J Dig Dis 1976; 21: 953–6PubMedCrossRef Nebel OT, Forties MF, Castell DO. Symptomatic gastroesophageal reflux incidence and precipitating factors. Am J Dig Dis 1976; 21: 953–6PubMedCrossRef
8.
Zurück zum Zitat Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med 1999; 72: 81–92PubMed Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med 1999; 72: 81–92PubMed
9.
Zurück zum Zitat Vallot T, Bruley des Varannes S, Grimaud JC, et al. Epidemiclogie du reflux gastro-oesophagien en medicine générale. Gastroenterol Clin Biol 1999; 23: 1139–44PubMed Vallot T, Bruley des Varannes S, Grimaud JC, et al. Epidemiclogie du reflux gastro-oesophagien en medicine générale. Gastroenterol Clin Biol 1999; 23: 1139–44PubMed
10.
Zurück zum Zitat Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 1589–94PubMedCrossRef Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 1589–94PubMedCrossRef
11.
Zurück zum Zitat Glise H. Quality of life and cost of therapy in reflux disease. Scand J Gastroenterol 1995; 30 Suppl. 210: 38–42CrossRef Glise H. Quality of life and cost of therapy in reflux disease. Scand J Gastroenterol 1995; 30 Suppl. 210: 38–42CrossRef
12.
Zurück zum Zitat Locke GR, Talley NJ, Felt SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmsted County Minnesota. Gastroenterology 1997; 112: 1448–56PubMedCrossRef Locke GR, Talley NJ, Felt SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmsted County Minnesota. Gastroenterology 1997; 112: 1448–56PubMedCrossRef
13.
Zurück zum Zitat Dent J, Brun J, Fendrick AM, on behalf of the Genval Workshop Group., et al. An evidence-based appraisal of reflux disease management: the Genval Workshop Report. Gut 1999; 44 Suppl. 2: S1–S16CrossRef Dent J, Brun J, Fendrick AM, on behalf of the Genval Workshop Group., et al. An evidence-based appraisal of reflux disease management: the Genval Workshop Report. Gut 1999; 44 Suppl. 2: S1–S16CrossRef
14.
Zurück zum Zitat O’Connor JB, Provenzale D, Brazer S. Economic considerations in the treatment of gastroesophageal reflux disease: a review. Am J Gastroenterol 2000; 95: 3356–64PubMedCrossRef O’Connor JB, Provenzale D, Brazer S. Economic considerations in the treatment of gastroesophageal reflux disease: a review. Am J Gastroenterol 2000; 95: 3356–64PubMedCrossRef
15.
Zurück zum Zitat Heading RC. Aims in the management of gastroesophageal reflux disease: a gastroenterologist’s viewpoint. Dis Esophagus 1999; 12: 1–6PubMedCrossRef Heading RC. Aims in the management of gastroesophageal reflux disease: a gastroenterologist’s viewpoint. Dis Esophagus 1999; 12: 1–6PubMedCrossRef
16.
Zurück zum Zitat Scott M, Gelhot AR. Gastroesophageal reflux disease: diagnosis and management. Am Fam Phys 1999; 59: 1161–9 Scott M, Gelhot AR. Gastroesophageal reflux disease: diagnosis and management. Am Fam Phys 1999; 59: 1161–9
17.
Zurück zum Zitat Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999; 231: 48–54PubMed Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999; 231: 48–54PubMed
18.
Zurück zum Zitat Havelund T, Lind T, Wiklund I. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol 1999; 94: 1782–9PubMedCrossRef Havelund T, Lind T, Wiklund I. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol 1999; 94: 1782–9PubMedCrossRef
19.
Zurück zum Zitat EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199–208CrossRef EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199–208CrossRef
20.
Zurück zum Zitat Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7: 75–83PubMedCrossRef Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7: 75–83PubMedCrossRef
21.
Zurück zum Zitat Dolan P, Gudex C, Kind P, et al. The time-trade-off method: results from a general population study. Health Econ 1996; 5: 141–54PubMedCrossRef Dolan P, Gudex C, Kind P, et al. The time-trade-off method: results from a general population study. Health Econ 1996; 5: 141–54PubMedCrossRef
22.
23.
Zurück zum Zitat Rentz AM, Battista C, Trudeau E, et al. Symptom and health-related quality-of-life measures for use in selected gastrointes-tinal disease studies. Pharmacoeconomics 2001; 19: 349–63PubMedCrossRef Rentz AM, Battista C, Trudeau E, et al. Symptom and health-related quality-of-life measures for use in selected gastrointes-tinal disease studies. Pharmacoeconomics 2001; 19: 349–63PubMedCrossRef
24.
Zurück zum Zitat Statistical analysis software, release 6.12. Cary (NC): SAS Institute Inc., 1989–1996 Statistical analysis software, release 6.12. Cary (NC): SAS Institute Inc., 1989–1996
25.
Zurück zum Zitat Euroqol EQ-5D user guide: a simple, generic measure validated in several countries measuring health for clinical and economic appraisal, supported by an international research group. Version B (1/98). Dordrecht: The EuroQol Foundation Euroqol EQ-5D user guide: a simple, generic measure validated in several countries measuring health for clinical and economic appraisal, supported by an international research group. Version B (1/98). Dordrecht: The EuroQol Foundation
26.
Zurück zum Zitat Wiklund I, Glise H. Quality of life in different gastrointestinal conditions. Fur J Surg Suppl 1998; 582: 56–61 Wiklund I, Glise H. Quality of life in different gastrointestinal conditions. Fur J Surg Suppl 1998; 582: 56–61
27.
Zurück zum Zitat Myers C, Wilks D. Comparison of EuroQol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Qual Life Res 1999; 8: 9–16PubMedCrossRef Myers C, Wilks D. Comparison of EuroQol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Qual Life Res 1999; 8: 9–16PubMedCrossRef
28.
Zurück zum Zitat Greiner W, Graf von der Schulenburg JM, Bergmann KC. Lebensqualität von erwachsenen Asthmapatienten. Pneumologie 1999; 53: 283–8PubMed Greiner W, Graf von der Schulenburg JM, Bergmann KC. Lebensqualität von erwachsenen Asthmapatienten. Pneumologie 1999; 53: 283–8PubMed
29.
Zurück zum Zitat Bardhan KD, Müller-Lissner S, Bigard MA, for the European Study Group, et al. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. BMJ 1999; 318: 502–7PubMedCrossRef Bardhan KD, Müller-Lissner S, Bigard MA, for the European Study Group, et al. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. BMJ 1999; 318: 502–7PubMedCrossRef
30.
Zurück zum Zitat Fass R, Pulliam G, Johnson C, et al. Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. Age Ageing 2000; 29: 125–30PubMedCrossRef Fass R, Pulliam G, Johnson C, et al. Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. Age Ageing 2000; 29: 125–30PubMedCrossRef
31.
Zurück zum Zitat Wilkins WE, Ridley MG, Pozniak AL. Benign stricture of the oesophagus: role on non-steroidal anti-inflammatory drugs. Gut 1984; 25: 478–80PubMedCrossRef Wilkins WE, Ridley MG, Pozniak AL. Benign stricture of the oesophagus: role on non-steroidal anti-inflammatory drugs. Gut 1984; 25: 478–80PubMedCrossRef
32.
Zurück zum Zitat Lanas A, Hirschowitz BI. Significant role of aspirin use in patients with esophagitis. J Clin Gastroenterol 1991; 13: 622–7PubMedCrossRef Lanas A, Hirschowitz BI. Significant role of aspirin use in patients with esophagitis. J Clin Gastroenterol 1991; 13: 622–7PubMedCrossRef
33.
Zurück zum Zitat El-Serag HB, Sonnenberg A. Non-steroidal anti-inflammatory drugs represent risk factors of erosions and peptic strictures of the esophagus. Am J Gastroenterol 1997; 92: 57–60 El-Serag HB, Sonnenberg A. Non-steroidal anti-inflammatory drugs represent risk factors of erosions and peptic strictures of the esophagus. Am J Gastroenterol 1997; 92: 57–60
34.
Zurück zum Zitat Schindlbeck NE, Klauser AG, Berghammer G, et al. Three year follow up of patients with gastrooesophageal reflux disease. Gut 1992; 33: 1016–9PubMedCrossRef Schindlbeck NE, Klauser AG, Berghammer G, et al. Three year follow up of patients with gastrooesophageal reflux disease. Gut 1992; 33: 1016–9PubMedCrossRef
35.
Zurück zum Zitat Sacher-Huvelin S, Gournay J, Amouretti M, et al. Esophage acidosensible: histoire naturelle et retentissement sur la qualité de vie. Gastroenterol Clin Biol 2000; 24: 911–6PubMed Sacher-Huvelin S, Gournay J, Amouretti M, et al. Esophage acidosensible: histoire naturelle et retentissement sur la qualité de vie. Gastroenterol Clin Biol 2000; 24: 911–6PubMed
36.
Zurück zum Zitat Agréus L. The epidemiology of functional gastrointestinal disorders. Fur J Surg Suppl 1998; 583: 60–6 Agréus L. The epidemiology of functional gastrointestinal disorders. Fur J Surg Suppl 1998; 583: 60–6
37.
Zurück zum Zitat Johansson KE, Ask P, Boeryd B, et al. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 837–47PubMedCrossRef Johansson KE, Ask P, Boeryd B, et al. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 837–47PubMedCrossRef
Metadaten
Titel
Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden
A study on patients’ burden of disease
verfasst von
Roger Jones
Silke Horbach
Dr Peter Sander
Tina Rydén-Bergsten
Publikationsdatum
01.10.2003
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 15/2003
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200321150-00003

Weitere Artikel der Ausgabe 15/2003

PharmacoEconomics 15/2003 Zur Ausgabe